KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Minority Interest (2016 - 2025)

Merck (MRK) has disclosed Minority Interest for 17 consecutive years, with $56.0 million as the latest value for Q4 2025.

  • Quarterly Minority Interest fell 5.08% to $56.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $56.0 million through Dec 2025, down 5.08% year-over-year, with the annual reading at $56.0 million for FY2025, 5.08% down from the prior year.
  • Minority Interest for Q4 2025 was $56.0 million at Merck, down from $57.0 million in the prior quarter.
  • The five-year high for Minority Interest was $94.0 million in Q1 2021, with the low at $49.0 million in Q2 2023.
  • Average Minority Interest over 5 years is $66.2 million, with a median of $66.0 million recorded in 2022.
  • The sharpest move saw Minority Interest plummeted 34.67% in 2023, then skyrocketed 34.69% in 2024.
  • Over 5 years, Minority Interest stood at $73.0 million in 2021, then dropped by 8.22% to $67.0 million in 2022, then fell by 19.4% to $54.0 million in 2023, then increased by 9.26% to $59.0 million in 2024, then fell by 5.08% to $56.0 million in 2025.
  • According to Business Quant data, Minority Interest over the past three periods came in at $56.0 million, $57.0 million, and $67.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.